Kellner Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-50,800
Closed -$8.78M 65
2015
Q1
$8.78M Buy
+50,800
New +$7.46M 5.75% 5

Other funds holding SLXP

Kellner Capital's SLXP Position: Q2 2015 in Review

Kellner Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 50,800 shares — an estimated $8.78M sold.

Kellner Capital first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $8.78M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Kellner Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Kellner Capital sold 50,800 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8.78M.
  • Kellner Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
  • Kellner Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $8.78M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Kellner Capital's 13F filing for Q2 2015, filed 10 Aug 2015.